MEDANTA — Global Health Cashflow Statement
0.000.00%
- IN₹359.29bn
- IN₹354.93bn
- IN₹36.92bn
Annual cashflow statement for Global Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 325 | 2,806 | 4,493 | 6,271 | 6,473 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 659 | 658 | 486 | 429 | 467 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 202 | -1,648 | -33.3 | -2,306 | -2,639 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2,418 | 3,113 | 6,445 | 6,121 | 6,238 |
Capital Expenditures | -1,457 | -2,745 | -2,360 | -2,786 | -6,479 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -934 | -1,464 | -1,064 | -1,622 | -730 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,392 | -4,209 | -3,423 | -4,408 | -7,209 |
Financing Cash Flow Items | -624 | -767 | -923 | -567 | -524 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -807 | 1,596 | 3,456 | -5,139 | -972 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -781 | 500 | 6,478 | -3,426 | -1,944 |